Business Wire

Hanshow and CGF Host DDVC Springboard EU, Spotlighting Retail Media Networks and AI-Powered In-Store Innovation

3.9.2025 08:53:00 CEST | Business Wire | Press Release

Share

Hanshow, a global leader in digital retail solutions, in partnership with The Consumer Goods Forum (CGF), hosted the Data-Driven Value Chain (DDVC) Springboard EU workshop at the Hanshow Amsterdam office on August 28, following a networking dinner on August 27. The curated program convened over 30 senior decision-makers from retailers, CPGs, media agencies and technology leaders under the theme “Integration Power: Synergy of Shopper, In-Store, and Retail Media for Sales Boost.”

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250902641164/en/

Ruediger Hagedorn, Director of DDVC

Sessions included a CGF & Hanshow opening and showroom tour, an expert panel on in-store marketing trends, Microsoft’s keynote on AI’s role in retail media, Hanshow use cases, an immersive Retail Journey Mapping Lab, and co-working session led by Microsoft.

Driving Ecosystem Collaboration Through Retail Media Networks

Opening the day, CGF’s Ruediger Hagedorn, Director of DDVC, set the collaborative tone and put interoperability at the centre, positioning DDVC as the place to unlock RMNs, shopper marketing and in-store activation through seamless data flow and shared insights: “Interoperability is key to unlocking seamless data flow and powerful insights. It enables a pre-competitive, collaborative approach to connecting with consumers, delivering a single, unified customer experience online and in-store.”

Building on that strategic frame, Nate Pinkston, Global Head of Retail Media at Microsoft, outlined how AI becomes the transformation engine for retail media—agentic commerce, real-time personalisation, cross-platform data harmonisation and adaptive media, adding: “AI is changing how people shop—shifting the shopping journey and where discovery happens. Retailers and brands need to start adapting now or risk falling behind.”

Translating strategy to shopfloor outcomes, Hanshow’s Dean of Retail Research Institute, Eason Tong showcased IoT-powered scenarios, from ESLs to smart trolleys — that transform physical stores into intelligent retail media environments: “I believe physical stores are the last goldmine of Retail Media Networks — capturing attention at the shelf is the key to driving brand growth.”

Immersive Session: Turning Stores into Intelligent Media Ecosystems

The Retail Journey Mapping Lab, co-led by Philippe Brochard, Board member and retail CEO, together with Hanshow’s Eason Tong and joined by leading retailers, CPGs, and media agency experts, was a highlight of the workshop. More than a discussion, it offered a live, in-situation experience showing how in-store retail media bridges online and offline into unified commerce ecosystems. Philippe emphasized that this integration turns every shopper touchpoint into a multiplier of revenue and engagement, creating shared, measurable value for all stakeholders.

Participants experienced first-hand how in-store retail media transforms every square meter into a performance-driven, monetizable asset. By blending online and offline behaviors, physical stores become intelligent data hubs that deliver personalized engagement at the exact moment of decision.

The session also underlined the collaborative nature of retail transformation:

  • For retailers, unlocking new revenue streams and measurable ROI on infrastructure.
  • For brands, precision targeting and attribution from discovery to purchase in real time.
  • For consumers, seamless, personalized commerce at the moment of choice.
  • For media and tech partners, programmatic buying, cross-channel orchestration, and new monetization models.

As Hanshow underlined: nothing replaces live experience. RMN is about imagining value creation together, in real time.

Hands-on Innovation at Hanshow’s Showroom

At Hanshow’s Showroom, guests experienced how the company’s digital solutions transform stores into measurable media environments. From electronic shelf labels (ESLs) and entrance displays to smart trolleys, Hanshow showcased an integrated stack that enables consistent campaign orchestration and real-time optimization of pricing, planograms, and on-shelf availability.

Demonstrations highlighted how ESLs now serve not only as pricing infrastructure but also as powerful in-store marketing touchpoints, linking shelves, mobile, and shopper journeys through NFC and AI-driven content delivery. With these innovations, retailers can unlock seamless promotions, shopper engagement, and data-driven insights—turning every store into an outcome-driven marketing environment.

The DDVC Springboard EU workshop underscored how Retail Media Networks are becoming the new growth engine for retail, transforming physical stores into intelligent, data-driven ecosystems where every touchpoint is measurable and monetizable. By convening retailers, brands, media agencies, and technology leaders, CGF and Hanshow showcased the power of pre-competitive collaboration to build interoperability, define shared standards, and unlock new revenue streams, marking a milestone in shaping a unified RMN community and accelerating the future of AI-powered, omnichannel retail media.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250902641164/en/

Contacts

info@hanshow.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye